Integrilin - 0085-1177-02 - (Eptifibatide)

Alphabetical Index


Drug Information of Integrilin

Product NDC: 0085-1177
Proprietary Name: Integrilin
Non Proprietary Name: Eptifibatide
Active Ingredient(s): 2    mg/mL & nbsp;   Eptifibatide
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Integrilin

Product NDC: 0085-1177
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020718
Marketing Category: NDA
Start Marketing Date: 19980518

Package Information of Integrilin

Package NDC: 0085-1177-02
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (0085-1177-02) > 100 mL in 1 VIAL, SINGLE-USE

NDC Information of Integrilin

NDC Code 0085-1177-02
Proprietary Name Integrilin
Package Description 1 VIAL, SINGLE-USE in 1 CARTON (0085-1177-02) > 100 mL in 1 VIAL, SINGLE-USE
Product NDC 0085-1177
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Eptifibatide
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19980518
Marketing Category Name NDA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name EPTIFIBATIDE
Strength Number 2
Strength Unit mg/mL
Pharmaceutical Classes Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]

Complete Information of Integrilin


General Information